Doctor Tushar Kotecha
Royal Free Hospital, London (United Kingdom of Great Britain & Northern Ireland)
Do the current guidelines define the right treatment for all acute pulmonary embolism patients at risk for cardiogenic shock?
Event: ESC Acute CardioVascular Care 2024
Topic: Pulmonary Embolism (PE)
Session: Bridging the gap between current acute pulmonary embolism patient management and the latest scientific insights
Myocardial perfusion mapping in cardiac amyloidosis- exploring the spectrum from infiltration to ischaemia
Event: ESC Congress 2019
Topic: Infiltrative Myocardial Disease
Session: Hot topics in myocardial and pericardial diseases
Quantitative CMR perfusion mapping to detect microvascular dysfunction in patients without obstructive coronary disease
Event: EuroCMR 2019
Topic: Stress Cardiac Magnetic Resonance (CMR)
Session: Rapid Fire Abstract 3: stress CMR: utility in coronary artery disease and beyond
Redefining assessment of adenosine stress response using CMR perfusion mapping: An alternative to splenic switch off
Event: EuroCMR 2019
Topic: Stress Cardiac Magnetic Resonance (CMR)
Session: Rapid Fire Abstract 3: stress CMR: utility in coronary artery disease and beyond
Quantification of myocardial infarct size and microvascular obstruction using dark-blood late gadolinium enhancement
Event: EuroCMR 2019
Topic: Late Gadolinium Enhancement
Session: Moderated ePosters session 2: frontiers in viability imaging
Follow up CMR to track treatment response in cardiac al amyloidosis
Event: EuroCMR 2017
Topic: Cardiac Magnetic Resonance
Session: Case session 1
Persistent circulating platelet and endothelial derived microparticle signature during 6 month follow up of patients undergoing PCI for ACS versus stable angina.
Event: ESC Congress 2016
Topic: Thrombosis and coagulation
Session: Thrombosis and antithrombotic in acute coronary syndrome
The incidence of abnormal ventilation/perfusion SPECT in pulmonary hypertension without chronic thromboembolism
Event: ESC Congress 2016
Topic: Hypertension, other
Session: Chronic pulmonary hypertension
Follow-up haemodynamic assessment as a predictor of survival in scleroderma-associated pulmonary arterial hypertension
Event: ESC Congress 2016
Topic: Chronic pulmonary hypertension
Session: Chronic pulmonary hypertension
ESC 365 is supported by
